XBIOTECH INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- XBIOTECH INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 0.00 shares.
- XBIOTECH INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 0.00 shares.
- XBIOTECH INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- XBIOTECH INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- XBIOTECH INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 0.00 shares, a 100.00% decline from fiscal 2024.
- XBIOTECH INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 50.77K shares, a 3961.36% increase from fiscal 2023.
- XBIOTECH INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 1.25K shares.
- XBIOTECH INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 0.00 shares, a 100.00% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | 0.00 shares derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-14 | 0.00 shares derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | 0.00 shares 10-K · filed 2026-03-13 |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | 8.32K shares derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | 24.57K shares derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | 0.00 shares 10-Q · filed 2026-05-14 | 36.85K shares derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | 8.32K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | 50.77K shares 10-K · filed 2026-03-13 |
| 2024-09-30 | 16.25K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | |
| 2024-06-30 | 12.28K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | |
| 2024-03-31 | 13.92K shares 10-Q · filed 2025-05-14 | |
| 2023-12-31 | 1.25K shares 10-K · filed 2025-03-18 | |
| 2023-03-31 | 0.00 shares derived: 10-Q 15 month − 10-K 12 month · filed 2023-05-10 | |
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | 0.00 shares 10-K · filed 2024-03-15 |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | |
| 2021-12-31 | 6.58K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | 1.10M shares 10-K · filed 2023-03-15 |
| 2021-09-30 | 350.14K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | 1.19M shares derived: sum of 4 quarters · filed 2022-03-15 |
| 2021-06-30 | 64.87K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | 1.17M shares derived: sum of 4 quarters · filed 2022-03-15 |
| 2021-03-31 | 678.40K shares 10-Q · filed 2021-05-10 | 1.15M shares derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-12-31 | 95.09K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | 1.80M shares 10-K · filed 2022-03-15 |
| 2020-09-30 | 327.14K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | 2.15M shares derived: sum of 4 quarters · filed 2021-03-16 |
| 2020-06-30 | 44.47K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | 1.89M shares derived: sum of 4 quarters · filed 2021-03-16 |
| 2020-03-31 | 1.33M shares 10-Q · filed 2020-05-11 | 1.91M shares derived: sum of 4 quarters · filed 2021-03-16 |
| 2019-12-31 | 443.17K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | 771.38K shares 10-K · filed 2021-03-16 |
| 2019-09-30 | 73.21K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | 408.21K shares derived: sum of 4 quarters · filed 2021-03-16 |
| 2019-06-30 | 64.10K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-12 | 398.00K shares derived: sum of 4 quarters · filed 2021-03-16 |
| 2019-03-31 | 190.90K shares 10-Q · filed 2019-05-09 | 333.40K shares derived: sum of 4 quarters · filed 2021-03-16 |
| 2018-12-31 | 80.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | 160.50K shares 10-K · filed 2021-03-16 |
| 2018-09-30 | 63.00K shares 10-Q · filed 2019-11-12 | 145.00K shares derived: sum of 4 quarters · filed 2020-03-16 |
| 2018-06-30 | -500.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | 100.00K shares derived: sum of 4 quarters · filed 2020-03-16 |
| 2018-03-31 | 81.00K shares 10-Q · filed 2018-10-31 | 305.50K shares derived: sum of 4 quarters · filed 2020-03-16 |
| 2017-12-31 | 1.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | 406.67K shares 10-K · filed 2020-03-16 |
| 2017-09-30 | 18.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | |
| 2017-06-30 | 205.00K shares 10-Q · filed 2017-11-09 | |
| 2017-03-31 | 66.41K shares 10-Q · filed 2017-05-10 | |
| 2016-12-31 | 204.16K shares 10-K/A · filed 2019-03-15 | |
| 2016-09-30 | 15.12K shares 10-Q · filed 2016-11-14 | 390.83K shares derived: sum of 4 quarters · filed 2017-03-16 |
| 2016-06-30 | 136.57K shares 10-Q · filed 2016-11-14 | 387.71K shares derived: sum of 4 quarters · filed 2017-03-16 |
| 2016-03-31 | 13.00K shares 10-Q · filed 2016-11-14 | 357.14K shares derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-12-31 | 226.14K shares 10-K · filed 2017-03-16 | 359.14K shares 10-K · filed 2018-03-16 |
| 2015-09-30 | 12.00K shares 10-Q · filed 2015-11-13 | |
| 2015-06-30 | 106.00K shares 10-K · filed 2017-03-16 | |
| 2015-03-31 | 15.00K shares 10-Q · filed 2015-11-13 | |
| 2014-12-31 | 15.00K shares 10-K · filed 2017-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |